Metraipolis › archive › dc_ed96addb3350
Long-Term Disease Control With Second-Line Nivolumab Monotherapy in Malignant Pleural Mesothelioma: A Case Report — Europe PMC PMID:42388949
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42388949
- DOI
- 10.7759/cureus.110026
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T22:53:28.194Z
- SHA-256 of the archived text
8a3a1f36932df038c5985c3da9b68479385d76c8d789d7f5061ea6db568c4009- Stable URL of this page
https://metraipolis.com/documento/dc_ed96addb3350
How to cite
Long-Term Disease Control With Second-Line Nivolumab Monotherapy in Malignant Pleural Mesothelioma: A Case Report — Europe PMC PMID:42388949 — Europe PMC (en), https://europepmc.org/article/MED/42388949 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ed96addb3350 (Metraipolis archive dc_ed96addb3350, sha256 8a3a1f36932df038c5985c3da9b68479385d76c8d789d7f5061ea6db568c4009)
BibTeX
@misc{dced96addb3350,
title = {Long-Term Disease Control With Second-Line Nivolumab Monotherapy in Malignant Pleural Mesothelioma: A Case Report — Europe PMC PMID:42388949},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42388949},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ed96addb3350; sha256 8a3a1f36932df038c5985c3da9b68479385d76c8d789d7f5061ea6db568c4009},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42388949. Agents can read the archived copy with the MCP tool read_document.